Form D · Biotechnology
Selva Nexus, Inc.
Albuquerque, NM · CIK 0002130905
Offering snapshot reported Apr 23, 2026 · SEC filing
- Reported sold
- $50K Offering amount: $750K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 10, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 23, 2026 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-581589
Source: Form D, filed Apr 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Weston Ross | Director, Executive, Promoter |
| Nicholas Spassil | Director, Executive, Promoter |
| Alexander Washburne | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1209 Mountain Road Pl Ne #11522
Albuquerque, NM, 87110
Albuquerque, NM, 87110